1. Home
  2. IMNM vs PATK Comparison

IMNM vs PATK Comparison

Compare IMNM & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$17.97

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Patrick Industries Inc.

PATK

Patrick Industries Inc.

HOLD

Current Price

$68.79

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
PATK
Founded
2006
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
IMNM
PATK
Price
$17.97
$68.79
Analyst Decision
Strong Buy
Buy
Analyst Count
17
11
Target Price
$35.19
★ $100.82
AVG Volume (30 Days)
★ 1.4M
597.6K
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
★ 2.67%
EPS Growth
★ 51.40
N/A
EPS
N/A
★ 2.37
Revenue
$6,941,000.00
★ $29,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,803.97
$4.98
P/E Ratio
★ N/A
$29.73
Revenue Growth
N/A
★ 262.50
52 Week Low
$14.64
$63.00
52 Week High
$30.06
$148.50

Technical Indicators

Market Signals
Indicator
IMNM
PATK
Relative Strength Index (RSI) 35.71 49.36
Support Level $17.83 $63.00
Resistance Level $23.48 $89.83
Average True Range (ATR) 0.98 2.13
MACD 0.14 0.95
Stochastic Oscillator 32.67 68.55

Price Performance

Historical Comparison
IMNM
PATK

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About PATK Patrick Industries Inc.

Patrick Industries Inc is a component solutions provider for the recreational vehicle (RV), marine, powersports, manufactured housing (MH), and various industrial markets, including single and multi-family housing, hospitality, institutional, and commercial markets. The company operates within two reportable segments, Manufacturing and Distribution. The majority of its revenue is generated from the Manufacturing segment, which offers laminated products utilized to produce furniture, shelving, walls, and countertops; fabricated aluminum products; cabinet products, doors, components, and custom cabinetry; interior passage doors and baggage doors; RV and marine furniture, etc. Geographically, the company mainly operates in the United States, with a small presence in Mexico, China, and Canada.

Share on Social Networks: